Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibition

Hepatology

Volumn 41, Issue 6, 2005, Pages 1241-1251

  Wang, LiFu ^a   Piguet, Anne Christine ^a   Schmidt, Karin ^a   Tordjmann, Thierry ^b   Dufour, Jean François ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CALCIUM; CASPASE 3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE C; TAUROURSODEOXYCHOLIC ACID; TEMSIROLIMUS;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BILE DUCT INJURY; CALCIUM SIGNALING; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BILE DUCTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYTOPROTECTION; PHOSPHORYLATION; PROTEIN KINASES; RATS; SIROLIMUS; TAUROCHENODEOXYCHOLIC ACID; TRANSCRIPTION, GENETIC;

EID: 20044395791     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20697     Document Type: Article

References (50)

1. Jaeschke H, Gujral JS, Bajt ML. Apoptosis and necrosis in liver disease. Liver Int 2004;24:85-89.
2. Celli A, Que FG. Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma. Semin Liver Dis 1998;18:177-185.
3. LeSage EG, Alvaro D, Benedetti A, Glaser S, Marucci L, Baiocchi L, et al. Cholinergic system modulates growth, apoptosis, and secretion of cholangiocytes from bile duct-ligated rats. Gastroenterology 1999;117:191-199.
4. Alpini G, Ueno Y, Tadlock L, Glaser SS, LeSage G, Francis H, et al. Increased susceptibility of cholangiocytes to tumor necrosis factor-alpha cytotoxicity after bile duct ligation. Am J Physiol Cell Physiol 2003;285:C183-194.
5. Tinmouth J, Lee M, Wanless IR, Tsui FW, Inman R, Heathcote EJ. Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. Liver 2002;22:228-234.
6. Paumgartner G, Beuers U. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis 2004;8:67-81, vi.
7. 2+ signals in isolated rat hepatocytes. Gastroenterology 1993;104:604-612.
8. Beuers U. Effects of bile acids on hepatocellular signaling and secretion. Yale J Biol Med 1997;70:341-346.
9. Kurz AK, Graf D, Schmitt M, Vom Dahl S, Haussinger D. Tauroursodes-oxycholate-induced choleresis involves p38(MAPK) activation and translocation of the bile salt export pump in rats. Gastroenterology 2001;121:407-419.
10. Noe J, Hagenbuch B, Meier PJ, St-Pierre MV. Characterization of the mouse bile salt export pump overexpressed in the baculovirus system. HEPATOLOGY 2001;33:1223-1231.
11. Beuers U, Bilzer M, Chittattu A, Kullak-Ublick GA, Keppler D, Paumgartner G, et al. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. HEPATOLOGY 2001;33:1206-1216.
12. Guicciardi ME, Gores GJ. Is ursodeoxycholate an antiapoptotic drug? HEPATOLOGY 1998;28:1721-1723.
13. Rodrigues CM, Steer CJ. The therapeutic effects of ursodeoxycholic acid as an anti-apoptotic agent. Expert Opin Invest Drugs 2001;10:1243-1253.
14. Benz C, Angermuller S, Otto G, Sauer P, Stremmel W, Stiehl A. Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes. Eur J Clin Invest 2000;30:203-209.
15. Rodrigues CMP, Fan G, Ma X, Kren BT, Steer CJ. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998;101:2790-2799.
16. Sola S, Ma X, Castro RE, Kren BT, Steer CJ, Rodrigues CM. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes. J Biol Chem 2003;278:48831-48838.
17. Sola S, Castro RE, Kren BT, Steer CJ, Rodrigues CM. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes. Biochemistry 2004;43:8429-8438.
18. Qiao L, Yacoub A, Studer E, Gupta S, Pei XY, Grant S, et al. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes. HEPATOLOGY 2002;35:779-789.
19. Schoemaker MH, Conde de la Rosa L, Buist-Homan M, Vrenken TE, Havinga R, Poelstra K, et al. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. HEPATOLOGY 2004;39:1563-1573.
20. Persengiev SP, Green MR. The role of ATF/CREB family members in cell growth, survival and apoptosis. Apoptosis 2003;8:225-228.
21. Wilson BE, Mochon E, Boxer LM. Induction of bcl-2 expression by phosphorylated CREB proteins during B-celi activation and rescue from apoptosis. Mol Cell Biol 1996;16:5546-5556.
22. Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2001;2:599-609.
23. Conkright MD, Guzman E, Flechner L, Su AI, Hogenesch JB, Montminy M. Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness. Mol Cell 2003;11:1101-1108.
24. Matthews RP, McKnight GS. Characterization of the cAMP response element of the cystic fibrosis transmembrane conductance regulator gene promoter. J Biol Chem 1996;271:31869-31877.
25. Woltje M, Kraus J, Hollt V. Identification of a functional 3′,5′-cyclic adenosine monophosphate response element within the second promoter of the mouse somatostatin receptor type 2 gene. FEBS Lett 1998;440:107-110.
26. Elit L. CCI-779 Wyeth. Curr Opin Investig Drugs 2002;3:1249-1253.
27. Jacinto E, Hall MN. Tor signalling in bugs, brain and brawn. Nat Rev Mol Cell Biol 2003;4:117-126.
28. Shamji AF, Nghiem P, Schreiber SL. Integration of growth factor and nutrient signaling: implications for cancer biology. Mol Cell 2003;12:271-280.
29. Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol 2004;24:200-216.
30. Huang S, Bjornsti MA, Houghton PJ. Rapamycins: mechanism of action and cellular resistance. Cancer Biol Ther 2003;2:222-232.
31. Neshat MS, Mellinghoff IK, Tran C, Stiles B, Thomas G, Petersen R, et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/ mTOR. Proc Natl Acad Sci USA 2001;98:10314-10319.
32. Vroman B, La Russo NF. Development and characterization of polarized primary cultures of rat intrahepatic bile duct epithelial cells. Lab Invest 1996;74:303-313.
33. Gonzalez GA, Montminy MR. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 1989;59:675-680.
34. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998;72:8463-8471.
35. Lowry O, Rosebrough N, Farr L, Randall R. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
36. Combettes L, Berthon B, Claret M. Caffeine inhibits cytosolic calcium oscillations induced by noradrenaline and vasopressin in rat hepatocytes. Biochem J 1994;301:737-744.
37. Tordjmann T, Berthon B, Jacquemin E, Clair C, Stelly N, Guillon G, et al. Receptor-oriented intercellular calcium waves evoked by vasopressin in rat hepatocytes. EMBO J 1998;17:4695-4703.
38. Nathanson MH, Burgstahler AD, Masyuk A, Larusso NF. Stimulation of ATP secretion in the liver by therapeutic bile acids. Biochem J 2001;358:1-5.
39. 2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 1991;252:1427-1430.
40. Chignard N, Mergey M, Veissiere D, Poupon R, Capeau J, Parc R, et al. Bile salts potentiate adenylyl cyclase activity and cAMP-regulated secretion in human gallbladder epithelium. Am J Physiol Gastrointest Liver Physiol 2003;284:G205-G212.
41. Shimokura GH, McGill JM, Schlenker T, Fitz JG. Ursodeoxycholate increases cytosolic calcium concentration and activates Cl- currents in a biliary cell line. Gastroenterology 1995;109:965-972.
42. 2+-, PKC-, and MAPK-dependent pathways. Am J Physiol Gastrointest Liver Physiol 2004;286:G973-G982.
43. 2+) signaling in rat bile duct epithelia by inositol 1,4,5-trisphosphate receptor isoforms. HEPATOLOGY 2002;36:284-296.
44. Thimmaiah KN, Easton J, Huang S, Veverka KA, Germain GS, Harwood FC, et al. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk 1-Erk2 and phosphatidylinositol 3′-kinase-Akt signaling pathways. Cancer Res 2003;63:364-374.
45. de Groot RP, Ballou LM, Sassone-Corsi P. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: an alternative route to mitogen-induced gene expression. Cell 1994;79:81-91.
46. Qiao L, Han SI, Fang Y, Park JS, Gupta S, Gilfor D, et al. Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes. Mol Cell Biol 2003;23:3052-3066.
47. Cha-Molstad H, Keller DM, Yochum GS, Impey S, Goodman RH. Cell-type-specific binding of the transcription factor CREB to the cAMP-response element. Proc Natl Acad Sci U S A 2004;101:13572-13577.
48. Tschopp J, Irmler M, Thome M. Inhibition of fas death signals by FLIPs. Curr Opin Immunol 1998;10:552-558.
49. Grambihler A, Higuchi H, Bronk SF, Gores GJ. cFLIP-L inhibits p38 MAPK activation: an additional anti-apoptotic mechanism in bile acid-mediated apoptosis. J Biol Chem 2003;278:26831-26837.
50. Huang S, Shu L, Easton J, Harwood FC, Germain GS, Ichijo H, et al. Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity. J Biol Chem 2004;279:36490-36496.